Bacterial and Fungal Pneumonia

Bacterial and fungal pneumonia in reptiles is a complex, often multifactorial respiratory disease characterized by inflammation and infection of the lung parenchyma and airways. Reptilian respiratory anatomy varies significantly among species: lizards and snakes possess paired, sac-like lungs with a cranial vascular portion and a caudal non-vascular faveolar region; chelonians (turtles and tortoises) have a rigid, non-expandable coelomic cavity with lungs attached dorsally, and their breathing relies on appendicular and visceral musculature. The disease can be acute or chronic, and may present as a primary infection or secondary to immunosuppression, poor husbandry, or concurrent disease. In snakes, pneumonia often manifests as a proliferative or exudative inflammation of the lung, sometimes with caseous plugs in the airways. In lizards, the lungs are more compartmentalized, and in chelonians, pneumonia can be associated with coelomitis or shell infections. The condition is a significant cause of morbidity and mortality in captive reptiles, particularly when environmental parameters (temperature, humidity, ventilation) are suboptimal.

Primary bacterial agents include Gram-negative organisms such as Aeromonas hydrophila, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Salmonella spp. Gram-positive bacteria like Staphylococcus aureus and Streptococcus spp. are less common but can occur. Mycoplasma spp. have been implicated in respiratory disease in tortoises and some lizards. Fungal etiologies include Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, and various zygomycetes. In snakes, inclusion body disease (IBD) caused by arenavirus can predispose to secondary bacterial pneumonia. Parasitic causes (e.g., lungworms in snakes, pentastomids) may also be involved but are not the primary focus. Environmental triggers include inadequate temperature gradients (hypothermia), high humidity or poor ventilation, overcrowding, poor sanitation, and stress. Nutritional deficiencies (e.g., hypovitaminosis A in chelonians) can impair mucosal immunity. Cellular mechanisms involve bacterial or fungal colonization of the respiratory epithelium, leading to inflammation, exudation, and impaired gas exchange.

Bacterial and fungal pneumonia affects all reptilian species kept in captivity, including snakes (e.g., ball pythons, boas, corn snakes), lizards (e.g., bearded dragons, iguanas, chameleons), and chelonians (e.g., red-eared sliders, box turtles, tortoises). There is no strong breed or strain predisposition, but age and sex can influence susceptibility: juveniles and geriatric animals are more vulnerable due to immature or senescent immune function. Husbandry factors are paramount: reptiles housed at suboptimal temperatures (below species-specific preferred optimal temperature zone) are immunocompromised. High humidity without proper ventilation promotes fungal growth. Overcrowding and poor hygiene increase bacterial load. Wild-caught reptiles may carry subclinical infections that flare under captive stress. Incidence rates are not well-documented but are common in clinical practice, especially in snakes and chelonians. Captive-bred animals with proper husbandry have lower risk.

The respiratory tract of reptiles is lined by ciliated epithelium in the trachea and primary bronchi, but the faveolar (lung) tissue is less efficient than mammalian alveoli. Bacteria or fungi inhaled or ascending from the oral cavity (e.g., stomatitis) adhere to the mucosa, overcoming mucociliary clearance. They release toxins and enzymes, causing epithelial necrosis and inflammation. Neutrophils (heterophils in reptiles) and macrophages infiltrate, leading to exudate accumulation. In snakes, the lung is elongated and extends caudally; exudate can pool in the caudal air sac, causing dyspnea. In chelonians, the rigid shell limits lung expansion, so pneumonia often leads to severe respiratory distress. Chronic infection can cause granuloma formation, fibrosis, and permanent loss of respiratory function. Systemic spread can occur, leading to septicemia and multi-organ failure. Fungal hyphae invade blood vessels, causing thrombosis and infarction. Impaired gas exchange results in hypoxia and hypercapnia, leading to metabolic acidosis.

Intrinsic factors include species-specific anatomy (e.g., elongated lungs in snakes, rigid shell in chelonians), metabolic rate (ectothermy means immune function is temperature-dependent), age (juveniles and seniors), and sex (reproductive stress in females). Extrinsic factors are critical: improper temperature gradients (too cold or too hot), inadequate humidity (too high or too low), poor ventilation (stale air, high ammonia), unsanitary enclosures (fecal contamination), overcrowding, poor nutrition (vitamin A deficiency, hypoproteinemia), and chronic stress (from handling, noise, or inadequate hiding spots). Concurrent diseases (e.g., renal disease, parasitism) can immunosuppress. Recent importation or quarantine failure can introduce pathogens.

Clinical signs vary by species and severity. Early signs include open-mouth breathing, increased respiratory effort, and audible wheezing or crackles. Reptiles may exhibit nasal discharge, which can be serous, mucoid, or purulent. Anorexia, lethargy, and weight loss are common. In snakes, there may be a 'snake huffing' sound, and the animal may hold its head elevated to facilitate breathing. In lizards, cyanosis of the oral mucous membranes may be seen. In chelonians, dyspnea may be evident as exaggerated limb movements or head bobbing. Chronic cases may show caseous exudate in the oral cavity or nares. Behavioral changes include reduced activity, hiding, and lack of basking. In severe cases, septicemia can cause petechiae, skin discoloration, and sudden death.

Differential diagnoses include: 1) Parasitic pneumonia (lungworms, pentastomids) - diagnosed by fecal floatation or bronchial wash cytology showing larvae/eggs. 2) Viral pneumonia (e.g., inclusion body disease in boids, paramyxovirus in snakes) - PCR testing and histopathology. 3) Aspiration pneumonia - history of improper force-feeding or regurgitation. 4) Neoplastic lung disease (e.g., pulmonary adenocarcinoma) - imaging and biopsy. 5) Trauma (e.g., rib fractures in chelonians) - radiography. 6) Congestive heart failure (rare) - echocardiography. 7) Toxic inhalation (e.g., ammonia) - history and environmental assessment. 8) Hypovitaminosis A - responds to vitamin A supplementation. Each differential requires specific diagnostic tests to rule in or out.

Step 1: Obtain a thorough history and perform a physical exam with species-safe restraint (e.g., clear plastic tube for snakes, towel for lizards, gentle handling for chelonians). Step 2: Assess respiratory rate and effort, listen for abnormal lung sounds (using a pediatric stethoscope or Doppler). Step 3: Perform a complete blood count and plasma biochemistry panel; venipuncture sites: ventral tail vein (snakes, lizards), jugular vein (chelonians, large lizards), or cranial vena cava (chelonians). Step 4: Obtain radiographs (dorsoventral and lateral views) to evaluate lung fields; in snakes, a horizontal beam may be needed. Step 5: If possible, perform tracheal wash or lung lavage for cytology and culture (a sterile catheter passed into the trachea under sedation). Step 6: Consider advanced imaging (CT) for detailed lung assessment. Step 7: Perform PCR testing for specific pathogens (e.g., Mycoplasma, arenavirus) on blood or swabs. Step 8: If a mass or granuloma is suspected, perform ultrasound-guided fine-needle aspiration or biopsy.

Hematology: Leukocytosis with heterophilia (increased heterophils) is common; toxic changes in heterophils may be seen. Monocytosis may occur in chronic infections. Anemia (low PCV) can be present. Thrombocytopenia may occur with sepsis. Serum biochemistry: Hyperglobulinemia (especially in chronic inflammation), hypoalbuminemia, and elevated AST and CK (if muscle damage). Uric acid may be elevated in renal disease. In chelonians, calcium and phosphorus may be altered. Fecal analysis: May reveal parasitic ova. PCR/Serology: Positive for Mycoplasma, Chlamydia, or arenavirus. Urinalysis: Not commonly performed but may show casts or proteinuria if systemic disease.

Radiography: In snakes, the lung appears as a radiolucent structure; pneumonia may show increased opacity, loss of detail, or air bronchograms. In lizards, the lungs are more cranial; patchy opacities may be seen. In chelonians, the lungs are dorsal; increased opacity or fluid lines may be visible. Ultrasonography: Can be used to assess lung parenchyma and detect fluid or masses; useful in chelonians to evaluate coelomic structures. CT: Provides high-resolution images of the lungs, useful for detecting granulomas, abscesses, or early changes. MRI: Less commonly used but can differentiate soft tissue masses. Endoscopy: Rigid endoscopy can be used to visualize the trachea and primary bronchi, collect samples, and assess the severity of inflammation.

Cytology from tracheal wash or lung lavage: May show heterophils, macrophages, bacteria (intracellular or extracellular), fungal hyphae (septate, branching for Aspergillus), and cellular debris. Gram stain can help identify bacterial type. Histopathology of lung biopsy: Acute pneumonia shows heterophilic infiltration, edema, and congestion. Chronic cases may show granulomatous inflammation with multinucleated giant cells, fibrosis, and necrosis. Fungal hyphae can be visualized with special stains (GMS, PAS). Inclusion bodies may be seen in viral infections. Neoplastic changes would show atypical cells.

Emergency stabilization: Provide supplemental oxygen (via mask or oxygen cage) and maintain optimal temperature (species-specific preferred optimal temperature zone). Fluid therapy: Administer isotonic crystalloids (e.g., LRS) at 20-30 ml/kg/day SC or IO; in severe dehydration, IV or IO boluses may be given. Assisted nutrition: If anorexic, syringe feed a species-appropriate diet (e.g., critical care formula for herbivores, carnivore diet for snakes). Antimicrobial therapy: Based on culture and sensitivity; initially, broad-spectrum antibiotics such as ceftazidime (20 mg/kg IM q72h for snakes, 20 mg/kg IM q72h for lizards, 20 mg/kg IM q72h for chelonians) or enrofloxacin (5-10 mg/kg PO/IM q24-48h, but avoid in young chelonians due to cartilage damage). For fungal pneumonia, use itraconazole (5-10 mg/kg PO q24h) or voriconazole (10 mg/kg PO q24h for birds, but in reptiles, 10-20 mg/kg PO q24h). Nebulization with antibiotics (e.g., amikacin 5 mg/ml) or antifungals (e.g., clotrimazole) can be effective. Surgical intervention: Rarely needed, but abscess drainage or granuloma removal may be considered. Husbandry corrections: Increase temperature, improve ventilation, reduce humidity if fungal, and ensure clean environment.

Short-term prognosis is guarded to good if treated early with appropriate antibiotics and supportive care. Medium-term prognosis depends on the extent of lung damage and underlying cause. Long-term prognosis is poor if chronic fibrosis or granuloma formation occurs. Negative prognostic indicators include severe dyspnea, cyanosis, septicemia, and lack of response to therapy within 48-72 hours. Recovery rates are higher in mild cases and with aggressive husbandry correction. Chronic cases may require lifelong management.

Re-check at 7-14 days after initiation of treatment: repeat physical exam, body weight, and blood work (CBC, biochemistry). Repeat radiographs or CT at 4-6 weeks to assess resolution. Adjust antimicrobial therapy based on culture results. Monitor temperature and humidity daily. Provide a stress-free environment. Long-term follow-up every 3-6 months for chronic cases. Educate owner on proper husbandry to prevent recurrence.

Pearls: Use a clear plastic tube for snake restraint to minimize stress. For venipuncture in snakes, use the ventral tail vein; in chelonians, the jugular vein is accessible. Nebulization is an effective adjunct to systemic therapy. Always culture and sensitivity before starting antibiotics. Maintain optimal temperature to enhance immune function. Pitfalls: Avoid using enrofloxacin in young chelonians due to cartilage damage. Do not use corticosteroids in reptiles as they are immunosuppressive. Avoid overhydration in chelonians due to risk of pulmonary edema. Do not rely solely on radiographs; CT is more sensitive. Do not neglect husbandry corrections; antibiotics alone will not cure pneumonia.

Antibiotics: Ceftazidime (20 mg/kg IM q72h) for snakes, lizards, and chelonians. Enrofloxacin (5-10 mg/kg PO/IM q24-48h) but avoid in young chelonians. Amikacin (5 mg/kg IM q72h) but monitor renal function. Piperacillin (100 mg/kg IM q48h) for Pseudomonas. Antifungals: Itraconazole (5-10 mg/kg PO q24h) for systemic fungal infections. Voriconazole (10-20 mg/kg PO q24h) for aspergillosis. Fluconazole (5-10 mg/kg PO q24h) for candidiasis. Nebulization: Amikacin (5 mg/ml) or ceftazidime (20 mg/ml) for 30-60 minutes q12h. Clotrimazole (1% solution) for nebulization. Fluid therapy: LRS at 20-30 ml/kg/day SC or IO. Analgesics: Meloxicam (0.1-0.2 mg/kg PO q24h) for pain. Prokinetics: Not typically used. Anti-parasitics: If concurrent parasites, fenbendazole (50 mg/kg PO q24h for 3 days) or ivermectin (0.2 mg/kg PO/SC, but avoid in chelonians).

Key studies include: 1) Jacobson ER et al. (1991) on mycoplasmosis in tortoises, highlighting the importance of PCR. 2) Murray MJ (1996) on pneumonia in snakes, emphasizing the role of husbandry. 3) Divers SJ (2010) on diagnostic imaging in reptiles, showing CT superiority. 4) Carpenter JW (2013) Exotic Animal Formulary provides dosing guidelines. 5) BSAVA Manual of Reptiles (2014) covers respiratory disease management. Consensus guidelines from ARAV recommend culture and sensitivity, nebulization, and husbandry correction. Recent research on voriconazole pharmacokinetics in reptiles supports its use for aspergillosis.